Glycorpotein antigen SIMA135 expressed in metastatic human tumor cells

Details for Australian Patent Application No. 2004213568 (hide)

Owner Novartis AG The Scripps Research Institute

Inventors Hooper, John D.; Testa, Jacqueline E.; Quigley, James P.

Agent Davies Collison Cave

Pub. Number AU-A-2004213568

PCT Pub. Number WO2004/074481

Priority 60/448,828 19.02.03 US

Filing date 18 February 2004

Wipo publication date 2 September 2004

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 016/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/074481 Priority application(s): WO2004/074481

10 August 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Glycoprotein antigen SIMA135 expressed in metastatic human tumor cells

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213570-Assay for the identification of protein SIC inhibitor

2004213566-Inactivated nodavirus vaccine